Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Genital herpes--how much of a public-health problem?

Literature DB >> 9652715

Genital herpes--how much of a public-health problem?

A Mindel¹.

Abstract

Mesh：

Substances：
Antiviral Agents

Year: 1998 PMID： 9652715 DOI： 10.1016/s0140-6736(98)90005-8

Source DB: PubMed Journal: Lancet ISSN： 0140-6736 Impact factor: 79.321

Keyword Cloud
Cited

× No keyword cloud information.

12 in total

1. Evaluation of an enzyme immunoassay system for measuring herpes simplex virus (HSV) type 1-specific and HSV type 2-specific IgG antibodies.

Authors: H E Prince; C E Ernst; W R Hogrefe
Journal: J Clin Lab Anal Date: 2000 Impact factor: 2.352

2. Public Health Strategies to Prevent Genital Herpes: Where Do We Stand?

Authors:
Journal: Curr Infect Dis Rep Date: 2000-02 Impact factor: 3.725

3. Digallate dimers of (-)-epigallocatechin gallate inactivate herpes simplex virus.

Authors: Charles E Isaacs; Weimin Xu; George Merz; Sharon Hillier; Lisa Rohan; Guang Y Wen
Journal: Antimicrob Agents Chemother Date: 2011-09-26 Impact factor: 5.191

4. Evaluation of the HerpeSelect Express rapid test in the detection of herpes simplex virus type 2 antibodies in patients with genital ulcer disease.

Authors: Hani Al-Shobaili; Khaled M Hassanein; Marwa Salah Mostafa; Ali Saleh Al Duways
Journal: J Clin Lab Anal Date: 2014-03-28 Impact factor: 2.352

5. Performance of the HerpeSelect (Focus) and Kalon enzyme-linked immunosorbent assays for detection of antibodies against herpes simplex virus type 2 by use of monoclonal antibody-blocking enzyme immunoassay and clinicovirological reference standards in Brazil.

Authors: Maria Claudia Nascimento; Suzete Ferreira; Ester Sabino; Ingrid Hamilton; John Parry; Claudio S Pannuti; Philippe Mayaud
Journal: J Clin Microbiol Date: 2007-05-16 Impact factor: 5.948

Genital herpes--how much of a public-health problem?

1. Evaluation of an enzyme immunoassay system for measuring herpes simplex virus (HSV) type 1-specific and HSV type 2-specific IgG antibodies.

2. Public Health Strategies to Prevent Genital Herpes: Where Do We Stand?

3. Digallate dimers of (-)-epigallocatechin gallate inactivate herpes simplex virus.

4. Evaluation of the HerpeSelect Express rapid test in the detection of herpes simplex virus type 2 antibodies in patients with genital ulcer disease.

5. Performance of the HerpeSelect (Focus) and Kalon enzyme-linked immunosorbent assays for detection of antibodies against herpes simplex virus type 2 by use of monoclonal antibody-blocking enzyme immunoassay and clinicovirological reference standards in Brazil.

6. Sexual and demographic risk factors for herpes simplex type 1 and 2 in women attending an antenatal clinic.

7. Theaflavin-3,3'-digallate and lactic acid combinations reduce herpes simplex virus infectivity.

8. A lipid-peptide microbicide inactivates herpes simplex virus.

9. HSV type specific serology in sexual health clinics: use, benefits, and who gets tested.

10. Epigallocatechin gallate inactivates clinical isolates of herpes simplex virus.